PixarBio Corporation announced that appointment of Jason Criscione as a Director for Drug Delivery Programs. Dr. Criscione joined PixarBio in March 2014 bringing his immunotherapy drug delivery and materials science experience to design, develop, and clinically translate biomaterials for sustained, local therapeutic intervention in neurological indications.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 81 | |
+25.24% | 45.32B | |
+34.85% | 24.51B | |
+29.56% | 16.85B | |
+21.32% | 14.62B | |
+70.51% | 14.16B | |
-0.05% | 6.79B | |
+15.74% | 5.82B | |
-8.87% | 5.73B | |
+10.29% | 4.93B |
- Stock Market
- Equities
- PXRB Stock
- News PixarBio Corporation
- PixarBio Corporation Appoints Jason Criscione as Director of Drug Delivery Programs